Marconi Medical Systems Gets FDA Clearance for Large-Bore Oncology CT Scanner

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 11
Volume 9
Issue 11

CLEVELAND-Marconi Medical Systems has received 510k clearance from the FDA to market its new ACQSIM CT scanner that addresses the special needs of oncology CT simulation and planning.

CLEVELAND—Marconi Medical Systems has received 510k clearance from the FDA to market its new ACQSIM CT scanner that addresses the special needs of oncology CT simulation and planning.

The ACQSIM CT scanner is designed with an 85-cm large bore, to simplify planning difficult cases, including breast, Hodgkin’s lymphoma, and large patients.

The acQsim system includes a high-precision localization and marking system and a virtual simulator that yield digitally composited and/or reconstructed radiographs that exceed the requirements of conformal and high-precision radiotherapy delivery, the company said.

The footprint of the new scanner is the same as that of standard 70-cm diagnostic CTs and is designed to fit into rooms that currently house a conventional simulator or CT scanner.

Several sites will be installed in 2000, the company said, with general product release scheduled for the spring of 2001.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
The use of guideline-concordant care in breast cancer appears to be more common in White populations than Black populations.
2 experts are featured in this series.
2 experts are featured in this series.
Retrospective and real-world registry studies may be necessary to guide clinical decision-making for rarer lymphomas with insufficient prospective data.
Extravasation results in exposing healthy tissue to radiation, which can be highly dosed depending on the isotope used for treatment.
4 experts in this video
Related Content